Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 15,900,000 shares, a growth of 10.6% from the April 30th total of 14,380,000 shares. Based on an average trading volume of 1,000,000 shares, the days-to-cover ratio […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) saw a large increase in short interest in May. As of May 15th, there was short interest totalling 15,900,000 shares, an increase of 10.6% from the April 30th total of 14,380,000 shares. Based on an average daily trading volume, of 1,000,000 shares, the days-to-cover ratio is currently […]
StockNews.com assumed coverage on shares of Anavex Life Sciences (NASDAQ:AVXL – Get Rating) in a research report sent to investors on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. AVXL has been the topic of a number of other reports. BTIG Research lowered their price target on Anavex Life Sciences from […]
StockNews.com started coverage on shares of Anavex Life Sciences (NASDAQ:AVXL – Get Rating) in a research note released on Thursday. The firm issued a sell rating on the biotechnology company’s stock. A number of other equities research analysts have also issued reports on AVXL. BTIG Research cut their target price on Anavex Life Sciences from […]
Anavex Life Sciences (NASDAQ:AVXL – Get Rating) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, May 9th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Anavex Life Sciences (NASDAQ:AVXL – Get Rating) last posted its quarterly earnings results on Tuesday, February 7th. […]